JR, C., SP, T., RF, K., & BN, F. (2023). Insulin sensitizers in 2023: Lessons learned and new avenues for investigation. Expert opinion on investigational drugs, 32(9), 803. https://doi.org/10.1080/13543784.2023.2263369
Chicago Style (17th ed.) CitationJR, Colca, Tanis SP, Kletzien RF, and Finck BN. "Insulin Sensitizers in 2023: Lessons Learned and New Avenues for Investigation." Expert Opinion on Investigational Drugs 32, no. 9 (2023): 803. https://doi.org/10.1080/13543784.2023.2263369.
MLA (9th ed.) CitationJR, Colca, et al. "Insulin Sensitizers in 2023: Lessons Learned and New Avenues for Investigation." Expert Opinion on Investigational Drugs, vol. 32, no. 9, 2023, p. 803, https://doi.org/10.1080/13543784.2023.2263369.
Warning: These citations may not always be 100% accurate.